Cat. No. | Product Name | Field of Application | Chemical Structure |
---|---|---|---|
DCC5125 | Thiazolidinedione-8 |
Novel antibiofilm agent, disturbing symbiotic balance between C. albicans and S. mutans in dual species biofilm
More description
|
![]() |
DCC5124 | Thiamphenicol Palmitate |
Prodrug of Thiamphenicol, inhibiting the 50S subunit of the bacterial ribosome and protein translation
More description
|
![]() |
DCC5123 | Thdp-17 |
Novel glutaminase activity inhibitor, showing a partial uncompetitive inhibition in vitro and a significant reduction of ammonia and glutamate production in vivo
More description
|
![]() |
DCC5122 | Thalassosamide |
Natural antibiotic, being active against P. aeruginosa both in vitro and in vivo.
More description
|
![]() |
DCC5121 | Thaigranatin T |
Natural potent human carboxylesterase 2 (hCES2) inhibitor (IC50: 5.05 μM)
More description
|
![]() |
DCC5120 | Th1027 |
Novel highly potent and specific inhibitor of TLR8, targeting an unconventional pocket on the TLR8 protein-protein Interface
More description
|
![]() |
DCC5119 | Tgx-155 |
Potent and selective inhibitor of PI 3-K
More description
|
![]() |
DCC5118 | Tgx-115 |
Cell-permeable, potent, and selective inhibitor of PI 3-K isoforms p110ß/p110d
More description
|
![]() |
DCC5117 | Tgr5-agonist-17 |
Novel Potent Agonist of TGR5 Receptor
More description
|
![]() |
DCC5116 | Tgr5 Agonist 11d-na |
Novel potent TGR5 agonist, displayind a significant glucose-lowering effect and stimulated GLP-1 and insulin secretion in TGR5H88Y mice but not in wild-type animals
More description
|
![]() |
DCC5115 | Tgp-200c |
Novel potent and structure-specific inhibitor of pre-miR-200c, reversing a type 2 diabetes phenotype
More description
|
![]() |
DCC5114 | Tg4-294-2 |
Potent and Selective Antagonist for Human EP2 Receptors
More description
|
![]() |
DCC5113 | tg4-292-1 |
Potent and selective nociceptin opioid receptor (NOP) agonist
More description
|
![]() |
DCC5112 | tg4-290-1 |
Potent and selective nociceptin opioid receptor (NOP) agonist
More description
|
![]() |
DCC5111 | Tg4-166 |
Potent and selective nociceptin opioid receptor (NOP) agonist
More description
|
![]() |
DCC5110 | Tg3-95-1 |
EP2 allosteric potentiator
More description
|
![]() |
DCC5109 | Tg2-in-3h |
Highly selective, potent, cell-permeable fluorescent irreversible tissue transglutaminase (TG2) inhibitor
More description
|
![]() |
DCC5108 | Tg-2112x |
Novel inhibitor of mitochondrial calcium uptake (#333333; font-family: "Open Sans", HelveticaNeue, "Helvetica Neue", Helvetica, Arial, sans-serif; font-size: 15px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight:
More description
|
![]() |
DCC5107 | Tg11-77 Hydrochloride |
Novel, Potent, Selective, Water Soluble, Brain-Permeable EP2 Receptor Antagonist
More description
|
![]() |
DCC5106 | Tg101114 |
Novel inhibitor of T315I mutant enzyme, exhibiting reasonable in vivo efficacy in a xenograft mouse model harboring T315I
More description
|
![]() |
DCC5105 | Tg100948 |
Novel dual VEGFR/Src kinase inhibitor
More description
|
![]() |
DCC5104 | Tg-0205221 |
Novel potent SARS coronavirus (CoV) 3CL protease inhibitor (Ki = 53 nM)
More description
|
![]() |
DCC5103 | Tg-0054 |
Novel and Potent Stem Cell Mobilizer; Inhibitor of SDF-1α/CXCR4 binding
More description
|
![]() |
DCC5102 | Tfr4oht |
Cyclized tamoxifen analog, selective ER modulator (SERM)
More description
|
![]() |
DCC5101 | Tfmo-12 |
CNS-penetrant selective class IIa histone deacetylase (HDAC) inhibitor, exploiting the >100-fold selectivity over class I/IIb HDACs
More description
|
![]() |
DCC5100 | Tfmo-1 |
Novel cell-active, selective class IIa HDAC inhibitor
More description
|
![]() |
DCC5099 | Tfgf-18 |
Novel GSK-3β inhibitor, showing anti-neuroinflammatory effects in lipopolysaccharide (LPS) activation of spontaneously immortalized SIM-A9 microglial cells and of mouse cortical microglia, inhibiting LPS-induced production of nitric oxide and the proinfla
More description
|
![]() |
DCC5098 | Tfah-10n |
Novel multipotent anti-Alzheimer agent, selectively inhibiting human butyrylcholinesterase (BChE), having strong antioxidant activity and good β-amyloid (Aβ) anti-aggregation properties
More description
|
![]() |
DCC5097 | Tezosentan |
Novel endothelin (ET) receptor antagonist
More description
|
![]() |
DCC5096 | Texasin |
Potent and selective human leukocyte 5-lipoxygenase (5-LOX) inhibitor
More description
|
![]() |